FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, particularly a new antituberculous drug which contains as an active substance dicalcium salt heptahydrate of paraaminosalicylic acid in a therapeutically effective and safe amount, and also pharmaceutically acceptable excipients. Besides, the invention refers to a method of treating tuberculosis.
EFFECT: drug under the invention exhibits smaller toxic effects, and also increased spectrum of bacteriostatic activity.
3 cl, 6 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
MEDICINE FOR TREATING TUBERCULOSIS | 2009 |
|
RU2487702C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
ANTITUBERCULOUS DRUG | 2009 |
|
RU2466722C2 |
MEDICATION FOR TUBERCULOSIS TREATMENT | 2009 |
|
RU2405554C1 |
ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
METHOD FOR PREPARING WATER-SOLUBLE CHITOSAN PARA-AMINOSALICYLATE | 2010 |
|
RU2440111C1 |
ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN SMALL DOSAGES VOLUME | 2014 |
|
RU2578433C1 |
Authors
Dates
2012-05-10—Published
2010-11-08—Filed